PSEUDO-NONCOMPETITIVE ANTAGONISM BY BQ123 OF INTRACELLULAR CALCIUM TRANSIENTS MEDIATED BY HUMAN ET(A) ENDOTHELIN RECEPTOR

被引:19
作者
SAKAMOTO, A
YANAGISAWA, M
TSUJIMOTO, G
NAKAO, K
TOYOOKA, T
MASAKI, T
机构
[1] KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT INTERNAL MED 2,KYOTO 606,JAPAN
[3] UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235
[4] UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235
[5] NATL CHILDRENS MED RES CTR,DEPT PHARMACOL,TOKYO 154,JAPAN
[6] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 2,TOKYO 154,JAPAN
关键词
D O I
10.1006/bbrc.1994.1504
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The family of endothelins, endothelin-1 (ET-1), ET-2 and ET-3, act on two subtypes of receptors called ET(A) and ET(B) receptors. BQ123 is an ET(A)-selective competitive antagonist. In this study, however, BQ123 inhibited ET-1-induced transients of cytosolic Ca2+ concentrations ([Ca2+]i) in an apparently noncompetitive manner in mouse L cell stably expressing cloned human ET(A) receptor. BQ123 (3 - 30 nM) did not change the EC50 of ET-1 (6.6 nM), but reduced the maximum responses down to 15.0 %. In an non-equilibrium binding assay which mimicks the conditions of [Ca2(+)]i transient assay (cells were incubated with [I-125]ET-1 only for 30 s), BQ123 (30 nM) constantly decreased the specific [I-125]ET-1 binding to approximate to 13% of that without the antagonist. Thus, the apparent noncompetitive antagonism by BQ123 of ET(A) receptor-mediated [Ca2+](i) transient is due to the assay condition where the interactions of the agonist, antagonist and receptor remained non-equilibrium state. (C) 1994 Academic Press, Inc.
引用
收藏
页码:679 / 686
页数:8
相关论文
共 25 条
[1]  
ARAMORI I, 1992, J BIOL CHEM, V267, P12468
[2]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[3]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97
[4]   REGIONAL VASODILATION TO ENDOTHELIN-1 IS MEDIATED BY A NON-ETA RECEPTOR SUBTYPE IN THE ANESTHETIZED RAT - EFFECT OF BQ-123 ON SYSTEMIC HEMODYNAMIC-RESPONSES [J].
DOUGLAS, SA ;
ELLIOTT, JD ;
OHLSTEIN, EH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 221 (2-3) :315-324
[5]   A NOVEL ETA ANTAGONIST (BQ-123) INHIBITS ENDOTHELIN-1-INDUCED PHOSPHOINOSITIDE BREAKDOWN AND DNA-SYNTHESIS IN RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
EGUCHI, S ;
HIRATA, Y ;
IHARA, M ;
YANO, M ;
MARUMO, F .
FEBS LETTERS, 1992, 302 (03) :243-246
[6]  
ELFAKAHANY EE, 1988, J PHARMACOL EXP THER, V247, P934
[7]   ENDOTHELIN RECEPTOR ANTAGONISM IS PROTECTIVE IN INVIVO ACUTE CYCLOSPORINE TOXICITY [J].
FOGO, A ;
HELLINGS, SE ;
INAGAMI, T ;
KON, V .
KIDNEY INTERNATIONAL, 1992, 42 (03) :770-774
[8]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[10]   BQ-123, CYCLO(-D-TRP-D-ASP-PRO-D-VAL-LEU), IS A NONCOMPETITIVE ANTAGONIST OF THE ACTIONS OF ENDOTHELIN-1 IN SK-N-MC HUMAN NEUROBLASTOMA-CELLS [J].
HILEY, CR ;
COWLEY, DJ ;
PELTON, JT ;
HARGREAVES, AC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) :504-510